Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpectraShield Technologies is a private U.S. company that develops and markets hydrogen peroxide-based disinfectant and decontamination products under the SpectraKill brand. The company positions its products as broad-spectrum, environmentally conscious solutions for household, commercial, agricultural, and chemical/biological decontamination applications. Its technology was originally formulated at Sandia National Laboratories with funding from U.S. government agencies and is sold as EPA-registered products including SpectraKill RTU and Spectra DF-500. While it is adjacent to healthcare through infection prevention and sanitation, it does not appear to be a therapeutics-focused biotech or pharma developer. The business is best characterized as a commercial disinfection and decontamination company rather than a drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpectraShield Technologies.